Views and analysis on Capital & Money Markets
What is happening at NNFM in 2026? Makes revenue but retains less
SEC’s bold steps by Joseph Edgar
Eterna Plc announces N21 billion Rights Issue: Investors takeaway
Vitafoam’s 300% surge in 2025: What should investors do in 2026?
Vitafoam in 2025: FX relief fuels profit growth, but inventory buildup demands caution
Fidson Healthcare announces N21 billion rights issue: Investor takeaways
2025 in Review: NSIA expands its role across Nigeria’s economy
Analysis: ARN Foods N7 billion Series 1 commercial paper
Champion Breweries’ N15.9 billion Rights Issue; more questions than answers
Fidson vs Mecure vs Neimeth: Which pharma stock offers better value for investors?
Where to Invest N10 Million in December 2025